Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Sickle cell disease: a natural model of acute and chronic pain.

Brandow AM, Zappia KJ, Stucky CL.

Pain. 2017 Apr;158 Suppl 1:S79-S84. doi: 10.1097/j.pain.0000000000000824. No abstract available.

PMID:
28221286
2.

Sickle Cell Trait and Renal Function in Hispanics in the United States: The Northern Manhattan Study.

Dueker ND, Della-Morte D, Rundek T, Sacco RL, Blanton SH.

Ethn Dis. 2017 Jan 19;27(1):11-14. doi: 10.18865/ed.27.1.11.

3.

Emergency department utilization by Californians with sickle cell disease, 2005-2014.

Paulukonis ST, Feuchtbaum LB, Coates TD, Neumayr LD, Treadwell MJ, Vichinsky EP, Hulihan MM.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26390. Epub 2016 Dec 21.

PMID:
28000344
4.

Translating sickle cell guidelines into practice for primary care providers with Project ECHO.

Shook LM, Farrell CB, Kalinyak KA, Nelson SC, Hardesty BM, Rampersad AG, Saving KL, Whitten-Shurney WJ, Panepinto JA, Ware RE, Crosby LE.

Med Educ Online. 2016 Nov 24;21:33616. doi: 10.3402/meo.v21.33616. eCollection 2016.

5.

Study protocol for a randomized controlled trial to assess the feasibility of an open label intervention to improve hydroxyurea adherence in youth with sickle cell disease.

Smaldone A, Findley S, Bakken S, Matiz LA, Rosenthal SL, Jia H, Matos S, Manwani D, Green NS.

Contemp Clin Trials. 2016 Jul;49:134-42. doi: 10.1016/j.cct.2016.06.004. Epub 2016 Jun 17.

6.

Community Health Workers as Support for Sickle Cell Care.

Hsu LL, Green NS, Donnell Ivy E, Neunert CE, Smaldone A, Johnson S, Castillo S, Castillo A, Thompson T, Hampton K, Strouse JJ, Stewart R, Hughes T, Banks S, Smith-Whitley K, King A, Brown M, Ohene-Frempong K, Smith WR, Martin M.

Am J Prev Med. 2016 Jul;51(1 Suppl 1):S87-98. doi: 10.1016/j.amepre.2016.01.016.

7.
8.

Pulmonary platelet thrombi and vascular pathology in acute chest syndrome in patients with sickle cell disease.

Anea CB, Lyon M, Lee IA, Gonzales JN, Adeyemi A, Falls G, Kutlar A, Brittain JE.

Am J Hematol. 2016 Feb;91(2):173-8. doi: 10.1002/ajh.24224.

9.
10.

A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children.

Brousseau DC, Scott JP, Badaki-Makun O, Darbari DS, Chumpitazi CE, Airewele GE, Ellison AM, Smith-Whitley K, Mahajan P, Sarnaik SA, Casper TC, Cook LJ, Dean JM, Leonard J, Hulbert ML, Powell EC, Liem RI, Hickey R, Krishnamurti L, Hillery CA, Nimmer M, Panepinto JA; Pediatric Emergency Care Applied Research Network (PECARN).

Blood. 2015 Oct 1;126(14):1651-7. doi: 10.1182/blood-2015-05-647107. Epub 2015 Jul 31.

11.

Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia.

Estepp JH, Melloni C, Thornburg CD, Wiczling P, Rogers Z, Rothman JA, Green NS, Liem R, Brandow AM, Crary SE, Howard TH, Morris MH, Lewandowski A, Garg U, Jusko WJ, Neville KA; Best Pharmaceuticals for Children Act-Pediatric Trials Network Administrative Core Committee.

J Clin Pharmacol. 2016 Mar;56(3):298-306. doi: 10.1002/jcph.598. Epub 2015 Oct 15.

12.

Blood transfusion and 30-day readmission rate in adult patients hospitalized with sickle cell disease crisis.

Nouraie M, Gordeuk VR.

Transfusion. 2015 Oct;55(10):2331-8. doi: 10.1111/trf.13155. Epub 2015 Jun 30.

13.

Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea.

Okam MM, Esrick EB, Mandell E, Campigotto F, Neuberg DS, Ebert BL.

Blood. 2015 Jun 4;125(23):3668-9. doi: 10.1182/blood-2015-03-635391. No abstract available.

14.

Socioeconomic and demographic characteristics of sickle cell disease patients from a low-income region of northeastern Brazil.

Fernandes TA, Medeiros TM, Alves JJ, Bezerra CM, Fernandes JV, Serafim ÉS, Fernandes MZ, Sonati Mde F.

Rev Bras Hematol Hemoter. 2015 May-Jun;37(3):172-7. doi: 10.1016/j.bjhh.2015.03.013. Epub 2015 Apr 14.

16.

Obstetrician-gynecologists' knowledge of sickle cell disease screening and management.

Azonobi IC, Anderson BL, Byams VR, Grant AM, Schulkin J.

BMC Pregnancy Childbirth. 2014 Oct 14;14:356. doi: 10.1186/1471-2393-14-356.

17.

Mortality of New York children with sickle cell disease identified through newborn screening.

Wang Y, Liu G, Caggana M, Kennedy J, Zimmerman R, Oyeku SO, Werner EM, Grant AM, Green NS, Grosse SD.

Genet Med. 2015 Jun;17(6):452-9. doi: 10.1038/gim.2014.123. Epub 2014 Sep 25.

18.

Perceived discrimination, patient trust, and adherence to medical recommendations among persons with sickle cell disease.

Haywood C Jr, Lanzkron S, Bediako S, Strouse JJ, Haythornthwaite J, Carroll CP, Diener-West M, Onojobi G, Beach MC; IMPORT Investigators.

J Gen Intern Med. 2014 Dec;29(12):1657-62. doi: 10.1007/s11606-014-2986-7. Epub 2014 Sep 10.

19.

Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, Meier ER, Howard TH, Majumdar S, Inusa BP, Telfer PT, Kirby-Allen M, McCavit TL, Kamdem A, Airewele G, Woods GM, Berman B, Panepinto JA, Fuh BR, Kwiatkowski JL, King AA, Fixler JM, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Dixon N, Gonzalez CE, Kalinyak KA, Quinn CT, Strouse JJ, Miller JP, Lehmann H, Kraut MA, Ball WS Jr, Hirtz D, Casella JF.

N Engl J Med. 2014 Aug 21;371(8):699-710. doi: 10.1056/NEJMoa1401731.

20.

State-based surveillance for selected hemoglobinopathies.

Hulihan MM, Feuchtbaum L, Jordan L, Kirby RS, Snyder A, Young W, Greene Y, Telfair J, Wang Y, Cramer W, Werner EM, Kenney K, Creary M, Grant AM.

Genet Med. 2015 Feb;17(2):125-30. doi: 10.1038/gim.2014.81. Epub 2014 Jul 3.

Supplemental Content

Support Center